NEW YORK (Reuters Health) – Wide variations in intraocular pressure (IOP) in glaucoma patients is associated with more progressive visual field loss, according to a report from the…
NEW YORK (Reuters Health) – Patients with type 2 diabetes without retinopathy can be safely screened for sight-threatening vision problems every 3 years instead of every 1 or…
NEW YORK (Reuters Health) – In a phase 2 study of patients with diabetic macular edema (DME), intravitreal injections of the vascular endothelial growth factor inhibitor, VEGF Trap-Eye,…
NEW YORK (Reuters Health) – Eye drops containing lubricants, corticosteroids, cyclosporine, or autologous serum improve dry eye symptoms associated with Sjögren’s syndrome (SS), according to a literature review.…
Marilyn Mann, OD, of Comprehensive Eye Care in Valley Cottage, NY, interviews Terry Peterson, Senior Sales Executive for Carl Zeiss Meditec, regarding the Cirrus HD-OCT, the most advanced…
NEW YORK (Reuters Health) –Tetracycline ointment should not be replaced by povidone iodine solution as prophylactic therapy for ophthalmia neonatorum, according to a study from Israel published in…
NEW YORK (Reuters Health) – Measurements of intraocular pressure (IOP) may depend on which eye is measured first, according to a new study published in the Archives of…
NEW YORK (Reuters Health) – Treating high-risk retinopathy of prematurity (ROP) early, before threshold severity is reached, preserves peripheral vision with relatively little reduction in visual field extent.…
NEW YORK (Reuters Health) – Results of an early phase trial indicate that wearing an experimental dual-focus soft contact lens can reduce myopia progression in children, according to…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…